Stay up to date
Latest News
- SRI and Scripps Institute collaborate to start the in vivo studies for SARS-CoV-2 vaccine as early as April 2020
March 2020 - FDA grants SRI its first investigator-initiated IND for expanded use of cord blood stem cells
March 2020 - Hep B Foundation and Blumberg Institute starts collaborating with SRI to run the validation studies of the potential HBV cure
March 2020 - SRI starts development of a virus-like-particle vaccine SRIvCOVID19 for SARS-Cov-2
February 2020 - FDA grants INTERACT meeting to discuss Dr. Gumrukcu’s potential HIV cure technology
February 2020 - SRI starts development of a nanoparticle RNA drug for a potential curative treatment for COVID19 based on the novel mechanism of action Dr Gumrukcu developed against HBV and Influenza virus
January 2020 - Dr. Gumrukcu presents preliminary HBV cure study data at HepDART 2019
December 2019 - SRI enters into agreement in principle with Enochian Biosciences to develop HBV cure
December 2019 - SRI starts collaboration with Scripps Institute on Dr. Gumrukcu’s potential HBV cure
July 2019